Drugs / H1N1sw vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01069367 | Mar → Apr 2010 | swine influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H1N1sw vaccine | “Subjects received 3.75μg of cell-derived H1N1sw vaccine formulated in half” NCT01069367 ↗ |
| Modality | Vaccine | “cell-derived A/H1N1 influenza HA vaccine” NCT01069367 ↗ |
| Route | Intramuscular | “All vaccination were administered IM in the deltoid muscle” NCT01069367 ↗ |